您当前所在的位置:首页 > 产品中心 > 产品详细信息
55079-83-9 分子结构
点击图片或这里关闭

9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid

ChemBase编号:72641
分子式:C21H26O3
平均质量:326.42934
单一同位素质量:326.18819469
SMILES和InChIs

SMILES:
c1c(c(c(c(c1C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C)C)C)OC
Canonical SMILES:
COc1cc(C)c(c(c1C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C
InChI:
InChI=1S/C21H26O3/c1-14(8-7-9-15(2)12-21(22)23)10-11-19-16(3)13-20(24-6)18(5)17(19)4/h7-13H,1-6H3,(H,22,23)/b9-7+,11-10+,14-8+,15-12+
InChIKey:
IHUNBGSDBOWDMA-AQFIFDHZSA-N

引用这个纪录

CBID:72641 http://www.chembase.cn/molecule-72641.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid
(2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid
IUPAC传统名
acitretin
(2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid
别名
9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid
Acitretin
Soriatane
Acitretin
(all-E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic Acid
Neotigason, Soriatane
Neotigason
Etretin
CAS号
55079-83-9
EC号
259-474-4
MDL号
MFCD00866632
PubChem SID
24868318
162037566
PubChem CID
5284513

理论计算性质

理论计算性质

JChem
Acid pKa 5.011076  质子受体
质子供体 LogD (pH = 5.5) 4.976502 
LogD (pH = 7.4) 3.2266924  Log P 5.5870485 
摩尔折射率 104.1665 cm3 极化性 38.030373 Å3
极化表面积 46.53 Å2 可自由旋转的化学键
里宾斯基五规则 false 

分子性质

分子性质

理化性质 安全信息 药理学性质 产品相关信息 生物活性(PubChem)
溶解度
Chloroform expand 查看数据来源
DMSO expand 查看数据来源
Methanol expand 查看数据来源
外观
Yellow Solid expand 查看数据来源
熔点
215-218°C (dec.) expand 查看数据来源
保存条件
-20°C expand 查看数据来源
Amber Vial, -20°C Freezer, Under Inert Atmosphere expand 查看数据来源
欧盟危险性物质标志
环境危害性(Nature polluting) 环境危害性(Nature polluting) (N) expand 查看数据来源
有毒(Toxic) 有毒(Toxic) (T) expand 查看数据来源
联合国危险货物编号
3077 expand 查看数据来源
MSDS下载
下载链接 expand 查看数据来源
下载链接 expand 查看数据来源
德国WGK号
3 expand 查看数据来源
联合国危险货物等级
9 expand 查看数据来源
联合国危险货物包装类别(PG)
3 expand 查看数据来源
危险公开号
61-36/38-50/53 expand 查看数据来源
安全公开号
53-26-45-60-61 expand 查看数据来源
GHS危险品标识
GHS07 expand 查看数据来源
GHS08 expand 查看数据来源
GHS09 expand 查看数据来源
GHS警示词
Danger expand 查看数据来源
GHS危险声明
H315-H319-H360-H410 expand 查看数据来源
GHS警示性声明
P201-P273-P305 + P351 + P338-P308 + P313-P501 expand 查看数据来源
个人保护装置
Eyeshields, full-face particle respirator type N100 (US), Gloves, respirator cartridge type N100 (US), type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges expand 查看数据来源
RID/ADR
UN 3077 9/PG 3 expand 查看数据来源
生物活性机理
Second generation retinoid expand 查看数据来源
纯度
≥98.0% (HPLC) expand 查看数据来源
成盐信息
Free Base expand 查看数据来源
质检报告
下载链接 expand 查看数据来源
应用领域
Active against epithelial tumours expand 查看数据来源
Used for treatment of psoriasis, antineoplastic agent expand 查看数据来源
Empirical Formula (Hill Notation)
C21H26O3 expand 查看数据来源

详细说明

详细说明

Selleck Chemicals Selleck Chemicals Sigma Aldrich Sigma Aldrich TRC TRC
Selleck Chemicals -  S1368 external link
Research Area: Inflammation
Biological Activity:
Acitretin is a second generation retinoid. It is taken orally, and is typically used for psoriasis. It is a metabolite of etretinate, which was used prior to the introduction of acitretin. Etretinate was discontinued because it had a narrow therapeutic index as well as a long elimination half-life (t1/2=120 days), making dosing difficult. In contrast, acitretin’s half-life is approximately 2 days. [1]
Sigma Aldrich -  44707 external link
Biochem/physiol Actions
Synthetic retinoid that is a metabolite of etretinate. Preferentially binds to cellular retinoic acid binding proteins (CRABPs).
Toronto Research Chemicals -  A189900 external link
A synthetic retinoid which is the major metabolite of etretinate (E938000).

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • http://en.wikipedia.org/wiki/Acitretin
  • Sato, T., et al.: J. Med. Chem., 51, 7705 (2008)
  • Liu, X., et al.: Cancer Chemother. Pharmacol., 63, 167 (2008)
  • Ger. Pat., 1977, 2 636 879; CA, 87, 23565y, (synth, deriv)
  • Haenni, R. et al., Helv. Chim. Acta, 1977, 60, 2309, (synth, pmr, ms, metab)
  • Mayer, H. et al., Experientia, 1978, 34, 1105, (rev, pharmacol)
  • Englert, G. et al., Helv. Chim. Acta, 1978, 61, 2697, (pmr, isom)
  • Paravicini, U. et al., Ann. N.Y. Acad. Sci., 1981, 359, 54, (rev, metab)
  • Ward, A. et al., Drugs, 1983, 26, 9, (rev)
  • Bestmann, H.J. et al., Annalen, 1984, 1740, (isoetretin)
  • Cunliffe, W.J., Biochem. Soc. Trans., 1986, 14, 943, (props)
  • Coffey, J.W. et al., Int. Congr. Ser. Excerpta Med., 1987, 750, 705, (rev, isomers)
  • Jakobsen, P. et al., J. Chromatogr., 1987, 415, 413, (hplc)
  • Pilkington, T. et al., Drugs, 1992, 43, 597, (rev)
  • Bouvy, M.L. et al., Pharm. Weekbl., Sci. Ed., 1992, 14, 33, (Acitretin, rev, pharmacokinet)
  • Martindale, The Extra Pharmacopoeia, 30th edn., Pharmaceutical Press, 1993, 754; 758
  • Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, EMJ500; REP400
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle